Clinical Trials Directory

Trials / Completed

CompletedNCT02401139

Ketamine Trial for the Treatment of Depression

Ketamine Therapy Among Patients With Treatment-resistant Depression: a Randomised, Double-blind, Placebo-controlled Trial: Pilot Phase

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (actual)
Sponsor
The University of New South Wales · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

This study is a Randomized Controlled Trial, investigating the safety and efficacy of administration of ketamine as a potential treatment for depression.

Conditions

Interventions

TypeNameDescription
DRUGKetamine
DRUGPlacebo

Timeline

Start date
2015-03-01
Primary completion
2015-07-01
Completion
2015-09-01
First posted
2015-03-27
Last updated
2023-03-30

Locations

2 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT02401139. Inclusion in this directory is not an endorsement.